Buzzworthy developments of the past few days: HHS has begun doing healthcare AI differently

Here’s a factoid you may not have seen coming. By 2030, the six countries of the Gulf Cooperation Council annually purchase more than $23 billion worth of products and services related to generative AI.

Compounded semaglutide injectable products are at the heart of these concerns. While the FDA says compounded drugs “can serve an important medical need for patients,” the agency does not approve these new formulations, increasing the risk of complications. 

A North Korean national who may or may not still reside in his home country has been indicted for allegedly leading ransomware attacks against U.S. hospitals.

Calling the legislation the Hospital Stability and Health Services Act, Sen. Tammy Baldwin (D-Wis.) suggests she wrote the bill with rural communities in mind.

Radiation-induced osteitis may not cause clinical symptoms, but its presence often sparks concerns about malignancy.

Dose reduction protocols vary across scanners and organizations. This can create inconsistencies in both image quality and measuring patients’ total radiation exposure. 

CVS should probably stop making job applicants face video lie detectors armed with emotion AI.